Information for COVID-19 Therapeutics Providers

This page contains information and resources for Texas COVID-19 therapeutics providers. Providers with questions can contact therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.

On this page:

• News & Updates
• Texas COVID-19 Product Availability
• How to Become a COVID-19 Therapeutics Provider
• Job Aids & FAQs
• Therapeutics Products
• Webinars
• Important Links
• Billing & Coding Information

News & Updates

More Provider Notices (PDFs)

• 5/17/22 DSHS letter to providers: HPOP Ordering Timeframe Updates Beginning 5/23/22
• 4/5/22 DSHS letter to providers: Sotrovimab No Longer Authorized as of 4/5/22

Weekly eDigests (PDFs)

• 7/5/22 Weekly eDigest: Evusheld Update on Repeat Dosing and Expiration Dates; REGEN-COV Shelf-life Extension; NIH Treatment Guidelines for Therapeutics; Reminder: Inventory Reporting Now Required Twice Per Week in HPOP; Requests for Bebtelovimab are Reviewed the Following Week; Check Short Dated Products for Expiration Date Extension; etc.
• 6/27/22 Weekly eDigest: Inventory Reporting Now Required Twice Per Week in HPOP; 4th of July Holiday: Shipping and Allocation; Reminder: Requests for Bebtelovimab are Reviewed the Following Week; NIH Treatment Guidelines for Therapeutics; Evusheld Updates Expected Soon; etc.

How to Become a COVID-19 Therapeutics Provider

To enroll as a therapeutics provider, please email therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.

Therapeutics Products

Click on any of the buttons below to access a list of product-specific resources.

For the latest information on product distribution across the state, see the Texas COVID-19 Product Availability section.

Monoclonal Antibody (mAb) Products

Bamlanivimab + Etesevimab (Lilly) Casirivimab + Imdevimab (Regeneron) Sotrovimab (GlaxoSmithKline) Bebtelovimab (Lilly)

Long-Acting Antibody (LAAB) Product

Evusheld: tixagevimab + cilgavimab (AstraZeneca)

Oral Antiviral Products

Lagevrio (molnupiravir) (Merck) Paxlovid: nirmatrelvir + ritonavir (Pfizer)

Important Links

• Health Partner Order Portal (HPOP) Provider Sign In
• COVID-19 Treatment Guidelines: Anti-SARS-CoV-2 Monoclonal Antibodies (NIH)
• NIH Statement on Therapies for High-Risk, Nonhospitalized Patients
• NIH Statement on Patient Prioritization for Outpatient Therapies
• NIH Statement on Evusheld for Pre-Exposure Prophylaxis
• SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests (FDA)
• COVID-19 Therapeutics (ASPR)
• Side-by-Side Overview of COVID-19 Therapeutics (ASPR)
• Comparison of Outpatient Therapies Effective Against Omicron Variant (TMA)
• COVID-19 Therapeutics Decision Aid (ASPR)

Texas COVID-19 Product Availability

• U.S. HHS COVID-19 Public Therapeutic Locator
• U.S. HHS Oral Antiviral Location Finder – including Test to Treat sites.

Job Aids & FAQs

• HPOP Provider Portal Help Center (Oracle)
• Therapeutics Product Guide – Job Aid (PDF, updated 6/17/2022)
• FAQs for Therapeutics Providers (PDF, V.6.0, updated 6/10/2022)

Webinars

• DSHS Evusheld Webinar (2/11/2022): Dosage updated since webinar was recorded. Please see Evusheld Fact Sheet for Healthcare Providers for current dosage and indications.
  • Video (Vimeo)
  • Slides (PDF)
• CDC COCA Call (6/16/2022): What Clinicians Need to Know About Available Therapeutic Options for COVID-19
• National Office Call Sessions: HHS / ASPR Allocation, Distribution, Administration of COVID-19 Therapeutics. Wednesdays 2:15-3:15 PM central. Please email COVID19Therapeutics@HHS.gov to request Zoom links for these calls.
• HHS COVID-19 Therapeutics Clinical Webinar: U.S. HHS hosts a roundtable on current COVID-19 topics every other Friday, 11:00 – noon central. Email COVID19Therapeutics@HHS.gov for more information on webinar dates and registration links.
• HHS Medical Professionals COVID-19 Roundtable: U.S. HHS hosts a roundtable on current COVID-19 topics every other Friday (opposite weeks from the therapeutics webinar above), 11:00 – noon central. Email COVID19Therapeutics@HHS.gov for more information on webinar dates and registration links.

Billing & Coding Information

• Centers for Medicare and Medicaid Services Provider Toolkit
• COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing
• CMS Monoclonal Antibody COVID-19 Infusion
• CMS Oral Antiviral Guidance
• CMS Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies
• U.S. HRSA COVID-19 Claims Reimbursement for Testing, Treatment, and Vaccine for the Uninsured

▲ Top